Screener
Quest Diagnostics DGX Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from Quest Diagnostics’s reported figures.
Based on the most recent quarter.
The source filing: Quest Diagnostics’s 10-Q, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 4:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001022079-26-000070
FAQ
- What is Quest Diagnostics's net debt / EBITDA?
- Quest Diagnostics (DGX) reported net debt / EBITDA of 2.6× in Q2 2026.
- How has Quest Diagnostics's net debt / EBITDA changed year-over-year?
- Quest Diagnostics's net debt / EBITDA decreased by 13.3% year-over-year, from 3× to 2.6×.
- What is the long-term trend for Quest Diagnostics's net debt / EBITDA?
- Over 5 years (2020 to 2025), Quest Diagnostics's net debt / EBITDA has grown at a 13.2% compound annual growth rate (CAGR), from 1.5× to 2.8×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.
Ask your AI about Quest Diagnostics's net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude